Form 4: Moleculin Biotech Chief Science Officer Donald H Picker Reports Stock Transactions
SEC Form 4 Filing
Donald H Picker, Chief Science Officer of Moleculin Biotech, Inc., reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On June 20, 2024, Donald H Picker, the Chief Science Officer of Moleculin Biotech, Inc., reported transactions involving the company's common stock.
- Picker acquired 1,078 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 320 shares were withheld for payment of taxes related to the vesting of these restricted stock units at a price of $3.78.
- Following these transactions, Picker directly owns 6,759 shares of Moleculin Biotech common stock and 28,124 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence and regulatory compliance.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The transactions have a minor impact on the overall share structure.
Key Dates
| Date | Description |
|---|---|
| 06/20/2022 | Reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 06/20/2024 | Date of transaction: vesting of restricted stock units and tax withholding. |
| 06/21/2024 | Date of signature on the Form 4 filing. |
Keywords
Moleculin Biotech, MBRX, Donald H Picker, Chief Science Officer, Form 4, Restricted Stock Units, Stock Transactions, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.